Medicare Enrolled
Dr. Mohammad Raja, MD
Cardiovascular Disease · El Paso, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Raja from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raja? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Raja
Dr. Mohammad Raja is a cardiovascular disease in El Paso, TX, with 20 years in practice. Based on federal Medicare data, Dr. Raja performed 8,314 Medicare services across 1,661 unique beneficiaries.
Between the years covered by Open Payments, Dr. Raja received a total of $311,595 from 63 pharmaceutical and/or device companies across 1351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Raja is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 5% volume in TX$ $311,595 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,314
Medicare services
Top 5% in TX for cardiovascular disease
1,661
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~416 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 5,801 | $0 | $0 |
| Office visit, established patient (30-39 min) | 802 | $86 | $309 |
| Electrocardiogram (EKG), 12-lead | 226 | $9 | $48 |
| Regadenoson injection (Lexiscan) for heart stress test | 220 | $41 | $231 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 151 | $8 | $31 |
| Injection, midazolam hydrochloride, per 1 mg | 114 | $0 | $0 |
| Echocardiogram, transthoracic | 95 | $133 | $642 |
| Injection, fentanyl citrate, 0.1 mg | 74 | $1 | $2 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 72 | $38 | $147 |
| Ultrasound of leg arteries or artery grafts | 64 | $172 | $688 |
| Ultrasound study of arm and leg arteries | 61 | $51 | $248 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 59 | $132 | $525 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 55 | $51 | $216 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 49 | $945 | $3,820 |
| New patient office visit (45-59 min) | 48 | $99 | $477 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 41 | $992 | $3,942 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 40 | $726 | $3,946 |
| Review by radiologist of abdominal aorta image | 40 | $92 | $430 |
| New patient office visit, complex (60-74 min) | 40 | $157 | $595 |
| Review by radiologist of both arms or legs arteries image | 37 | $124 | $592 |
| Hospital follow-up visit, moderate complexity | 32 | $61 | $211 |
| Removal of plaque in arteries of leg | 30 | $6,118 | $30,832 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 27 | $1,049 | $4,462 |
| Programming of dual lead pacemaker system | 25 | $51 | $168 |
| Office visit, established patient (20-29 min) | 20 | $65 | $209 |
| Removal of plaque in artery of leg, initial vessel | 15 | $6,781 | $30,382 |
| Balloon dilation of artery of leg, initial vessel | 14 | $371 | $15,380 |
| Review by radiologist of arm or leg artery image | 14 | $63 | $495 |
| Ultrasound of leg arteries at rest and after exercise | 14 | $16 | $488 |
| Office visit, established patient, complex (40-54 min) | 12 | $137 | $415 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $19 | $79 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 11 | $632 | $2,031 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
78.7% medium
19.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$311,595
Total received (2018-2024)
Avg $44,514/year across 7 years
Top 1% in TX for cardiovascular disease
63
Companies
1,351
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$179,331 (57.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$105,812 (34.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,452 (8.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$42,764
2023$18,819
2022$38,512
2021$32,194
2020$27,916
2019$63,997
2018$87,394
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$66,908
Terumo Medical Corporation
$55,908
Medtronic Vascular, Inc.
$42,229
Philips Electronics North America Corporation
$40,329
Cardiovascular Systems Inc.
$35,685
Philips North America LLC
$13,530
ShockWave Medical, Inc
$12,556
Abbott Laboratories
$8,220
Janssen Scientific Affairs, LLC
$5,344
Penumbra, Inc.
$3,861
Otsuka Pharmaceutical Development & Commercialization, Inc.
$3,675
Janssen Pharmaceuticals, Inc
$3,249
Inari Medical, Inc.
$3,139
AngioDynamics, Inc.
$1,773
CORDIS US CORP.
$1,474
Bard Peripheral Vascular, Inc.
$1,267
Intact Vascular, Inc.
$1,142
Novartis Pharmaceuticals Corporation
$1,118
W. L. Gore & Associates, Inc.
$1,062
E.R. Squibb & Sons, L.L.C.
$732
Amgen Inc.
$703
Shockwave Medical, Inc
$673
PFIZER INC.
$636
Boston Scientific Corporation
$467
Surmodics, Inc.
$454
BIOTRONIK INC.
$441
Endologix LLC
$418
Reflow Medical Inc
$401
ASAHI INTECC USA, INC.
$373
Boehringer Ingelheim Pharmaceuticals, Inc.
$366
ABIOMED
$364
BOSTON SCIENTIFIC CORPORATION
$340
LimFlow Inc.
$317
Integra LifeSciences Corporation
$254
Osiris Therapeutics Inc.
$229
Astellas Pharma US Inc
$206
Cagent Vascular INC
$200
Merck Sharp & Dohme LLC
$199
EKOS Corporation
$183
SANOFI-AVENTIS U.S. LLC
$155
Amarin Pharma Inc.
$107
Misonix Inc
$93
Smith+Nephew, Inc.
$90
Orthofix Medical, Inc.
$85
AstraZeneca Pharmaceuticals LP
$83
Veryan Medical Incorporated
$80
Tactile Systems Technology Inc
$72
Terumo BCT, Inc.
$47
Braemar Manufacturing, LLC
$37
Reapplix Inc.
$36
Gilead Sciences, Inc.
$34
Lexicon Pharmaceuticals, Inc.
$31
Chiesi USA, Inc.
$28
Impulse Dynamics (USA) Inc.
$24
Ra Medical Systems, Inc.
$23
Novo Nordisk Inc
$22
SCPHARMACEUTICALS INC.
$21
Insmed, Inc.
$19
Regeneron Healthcare Solutions, Inc.
$19
Z-Medica, LLC
$18
Lantheus Medical Imaging, Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$14
CHIESI USA, INC.
$12
Top 3 companies account for 53.0% of total payments
Associated products mentioned in payments ›
(2870) Laser serv Undiv · (4067) Tack Endovascular Systems BTK · (6342) Intrasight Integrated · (6554) Periph Vasc Undiv · (6554) Peripheral Vascular Undivided · (6577) Visions 014 · (6582) Visions 035 · (6585) Omniwire · (6586) Pioneer · (8334) IGT D Peripheral · (888) PV 018 OTW · (9263) QC Capture · (9266) ELCA · (9281) Turbo Elite · (9282) Turbo Power · (9284) Stellarex · (9520) IGT Devices Und · (9520) IGT Devices Undivided · (9547) IGT Systems Und · (BR5) Peripheral IVUS · (BR7) Peripheral Specialty Balloon · (BR8) Peripheral Thrombectomy · (BR9) Crossing · (BS1) Peripheral Vascular Undivided · 3C Patch Kit - Box · ABRE · ASAHI PTCA Guide Wire · AURYON LASER SYSTEM 100-120 VAC · AVVIGO Guidance System · AZUR · Abre · Advisa · Allure CRT Pacemaker · Allure Quadra RF CRT Pacemaker · AngioSeal · Arikayce · Armada 35 percutaneous catheter · Asahi Fielder coronary guide wire · Assurity Pacemaker · Auryon Laser System 100-120 Vac · BRILINTA · BRITE TIP · BioMimics · CAMZYOS · CHANTIX · CLEVIPREX 25MG/50ML · CT THROMBECTOMY SYSTEM KIT · CVX-300 · Cardiac Monitoring Suite · Chocolate PTA Balloon · Confirm Rx · CoreValve Evolut · Corlanor · DABRA · DEFINITY · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · Diamondback Peripheral · Durata Defibrillation ICD Lead · EKOSONIC · ELIQUIS · EMBOSHIELD NAV6 · ENDOCROSS Device · ENDURANT IIS · ENTRESTO · ESPRIT · Edarbi · Ellipse ICD · Ellipsys · Endurant · FARXIGA · FLEXITOUCH · FLOWMET · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · Foot & Ankle · Fortify Assura · Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter · GENERAL VASCULAR INTERVENTION · GLIDESHEATH SLENDER · GORE VIABAHN Endoprosthesis · GORE VIABAHN VBX Balloon Expandable Endo · GRAFIX/GRAFIXPL/STRAVIX · General - Vascular Intervention · GlideWire · Glidesheath · HARVEST BMAC · HAWKONE · HawkOne · Heartrail · Hi-Torque Command guide wire · IGT D Coronary · IGT D Peripheral · IGT Und · IGT_D Peripheral · IGT_D Therapy · IN.PACT ADMIRAL · IN.PACT Admiral · INTEGRA MESHED BILAYER WOUND MATRIX · IVUS Systems · Impella · Indigo · JARDIANCE · JETSTREAM · JYNARQUE · KENGREAL · LATITUDE · LEQVIO · LEXISCAN · LIMFLOW SYSTEM · LINQ II · LUTONIX · MULTAQ · MV Bio-Med Others SV · MYNX CONTROL · Merlin Connectivity and Remote · MetaCross · Micra · NAVICROSS · Navicross · OMNIGRAFT · ONYX FRONTIER · OPTIMIZER · Optisure Defibrillation ICD Lead · Ozempic · PERIPHERAL VASCULAR · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Passeo-18 · Penumbra System · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Pounce Thrombectomy System · Pulsar-18 T3 · QT Vascular Chocolate PTA Balloon · QUIKCLOT · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · R2P MISAGO · RADIAL 360 · RAIDEN3T · RENASYS GO v2 HOME · RESOLUTE ONYX · ROTABLATOR · ROTAPRO · Ranger · Repatha · Resolute · Reveal LINQ · Rotarex · S · SELUTION SLRPTA · SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE M5+ · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SILVERHAWK · SPIDERFX · STEALTH AUTOGUIDE SYSTEM · SYMPLICITY G3 · Serrantor · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripher · StarClose SE vascular closure system · Stellarex · Stravix · Sublime 014 Rx PTA Balloon Dilatation Catheter · Supera peripheral stent system · TAG Thoracic Endoprosthesis · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TR Band · TRAILBLAZER · TURBOHAWK · TYRX · Tack Endovascular System · Torus Stent Graft System · Trilogy 100 · TurboHawk · ULTRAVERSE · Unify Assura CRT Defibrillator · VALEO · VENASEAL · VENOVO · VERQUVO · VIABAHN Endoprosthesis · VIABAHN Endoprosthesis with PROPATEN Bioactive Surface · VIABAHN VBX Balloon Expandable Endoprosthesis · VIAGRA · VYNDAQEL · Vascepa · Vascular Lithotripsy · Viance · WATCHMAN · XARELTO · Xience Alpine cornary stent system
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for cardiovascular disease in TX.
Equivalent to $3,748 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
34
Per 100K population
3.9
County median income
$58,859
Nearest hospital
THE HOSPITALS OF PROVIDENCE - MEMORIAL CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Raja is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), and high industry engagement (speaking/promotional, top 1%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Raja experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Raja performed 5,801 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Raja receive payments from pharmaceutical companies?
Yes. Dr. Raja received a total of $311,595 from 63 companies across 1,351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raja's costs compare to other cardiovascular diseases in El Paso?
Dr. Raja's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raja) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in El Paso
Browse cardiovascular diseases in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Terumo Medical Corporation Payments to Doctors
See all physicians who received payments from Terumo Medical Corporation.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology